Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialMarshall R. Posner, Kevin J. Cullen, Jochen H. Lorch et al.|Annals of Oncology|2011Cited by 487
Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer PatientsKathleen Settle, Kevin J. Cullen, Marshall R. Posner et al.|Cancer Prevention Research|2009Cited by 297
Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.Matthew J. Ellis, Robert Clarke, Vered Stearns et al.|PubMed|2002Cited by 114
β-Tubulin-II Expression Strongly Predicts Outcome in Patients Receiving Induction Chemotherapy for Locally Advanced Squamous Carcinoma of the Head and Neck: A Companion Analysis of the TAX 324 TrialKevin J. Cullen, Marshall R. Posner, Lisa M. Schumaker et al.|Journal of Clinical Oncology|2009Cited by 59
Novel biomarker panel predicts prognosis in human papillomavirus‐negative oropharyngeal cancerYin Wu, Kevin J. Cullen, Marshall R. Posner et al.|Cancer|2011Cited by 29